Literature DB >> 22854959

Light chain of factor VIII is sufficient for accelerating cleavage of von Willebrand factor by ADAMTS13 metalloprotease.

Wenjing Cao1, Denise E Sabatino, Ekaterina Altynova, Amy M Lange, Veronica C Casina, Rodney M Camire, X Long Zheng.   

Abstract

We previously demonstrated that coagulation factor VIII (FVIII) accelerates proteolytic cleavage of von Willebrand factor (VWF) by A disintegrin and metalloprotease with thrombospondin type 1 repeats (ADAMTS13) under fluid shear stress. In this study, the structural elements of FVIII required for the rate-enhancing effect and the biological relevance of this cofactor activity are determined using a murine model. An isolated light chain of human FVIII (hFVIII-LC) increases proteolytic cleavage of VWF by ADAMTS13 under shear in a concentration-dependent manner. The maximal rate-enhancing effect of hFVIII-LC is ∼8-fold, which is comparable with human full-length FVIII and B-domain deleted FVIII (hFVIII-BDD). The heavy chain (hFVIII-HC) and the light chain lacking the acidic (a3) region (hFVIII-LCΔa3) have no effect in accelerating VWF proteolysis by ADAMTS13 under the same conditions. Although recombinant hFVIII-HC and hFVIII-LCΔa3 do not detectably bind immobilized VWF, recombinant hFVIII-LC binds VWF with high affinity (K(D), ∼15 nM). Moreover, ultra-large VWF multimers accumulate in the plasma of fVIII(-/-) mice after hydrodynamic challenge but not in those reconstituted with either hFVIII-BDD or hFVIII-LC. These results suggest that the light chain of FVIII, which is not biologically active for clot formation, is sufficient for accelerating proteolytic cleavage of VWF by ADAMTS13 under fluid shear stress and (patho) physiological conditions. Our findings provide novel insight into the molecular mechanism of how FVIII regulates VWF homeostasis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22854959      PMCID: PMC3463299          DOI: 10.1074/jbc.M112.390690

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

Review 1.  Thrombotic thrombocytopenic purpura: the systemic clumping "plague".

Authors:  Joel L Moake
Journal:  Annu Rev Med       Date:  2002       Impact factor: 13.739

2.  Size regulation of von Willebrand factor-mediated platelet thrombi by ADAMTS13 in flowing blood.

Authors:  Roberta Donadelli; Jennifer N Orje; Cristina Capoferri; Giuseppe Remuzzi; Zaverio M Ruggeri
Journal:  Blood       Date:  2005-11-17       Impact factor: 22.113

3.  Reduced von Willebrand factor-cleaving protease (ADAMTS13) activity in acute myocardial infarction.

Authors:  K Kaikita; K Soejima; M Matsukawa; T Nakagaki; H Ogawa
Journal:  J Thromb Haemost       Date:  2006-08-08       Impact factor: 5.824

4.  High von Willebrand factor levels increase the risk of first ischemic stroke: influence of ADAMTS13, inflammation, and genetic variability.

Authors:  Tamara N Bongers; Moniek P M de Maat; Mary-Lou P J van Goor; Vinod Bhagwanbali; Huub H D M van Vliet; Encarna B Gómez García; Diederik W J Dippel; Frank W G Leebeek
Journal:  Stroke       Date:  2006-09-21       Impact factor: 7.914

5.  Serial changes in von Willebrand factor-cleaving protease (ADAMTS13) and prognosis after acute myocardial infarction.

Authors:  Masakazu Matsukawa; Koichi Kaikita; Kenji Soejima; Shunichiro Fuchigami; Yoshinori Nakamura; Tsuyoshi Honda; Kenichi Tsujita; Yasuhiro Nagayoshi; Sunao Kojima; Hideki Shimomura; Seigo Sugiyama; Kazuteru Fujimoto; Michihiro Yoshimura; Tomohiro Nakagaki; Hisao Ogawa
Journal:  Am J Cardiol       Date:  2007-06-12       Impact factor: 2.778

6.  Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.

Authors:  H M Tsai; E C Lian
Journal:  N Engl J Med       Date:  1998-11-26       Impact factor: 91.245

7.  von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.

Authors:  M Furlan; R Robles; M Galbusera; G Remuzzi; P A Kyrle; B Brenner; M Krause; I Scharrer; V Aumann; U Mittler; M Solenthaler; B Lämmle
Journal:  N Engl J Med       Date:  1998-11-26       Impact factor: 91.245

8.  The enhancing effects of the light chain on heavy chain secretion in split delivery of factor VIII gene.

Authors:  Lingxia Chen; Fuxiang Zhu; Juan Li; Hui Lu; Haiyan Jiang; Rita Sarkar; Valder R Arruda; Jinhui Wang; Jennifer Zhao; Glenn F Pierce; Qiulan Ding; Xuefeng Wang; Hongli Wang; Steven W Pipe; Xiang-Qin Liu; Xiao Xiao; Rodney M Camire; Weidong Xiao
Journal:  Mol Ther       Date:  2007-07-24       Impact factor: 11.454

9.  Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion.

Authors:  H M Tsai
Journal:  Blood       Date:  1996-05-15       Impact factor: 22.113

10.  The cooperative activity between the carboxyl-terminal TSP1 repeats and the CUB domains of ADAMTS13 is crucial for recognition of von Willebrand factor under flow.

Authors:  Ping Zhang; Weilan Pan; Ann H Rux; Bruce S Sachais; X Long Zheng
Journal:  Blood       Date:  2007-05-31       Impact factor: 22.113

View more
  9 in total

Review 1.  Structure-function and regulation of ADAMTS-13 protease.

Authors:  X L Zheng
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

2.  Normal cleavage of von Willebrand factor by ADAMTS-13 in the absence of factor VIII in patients with severe hemophilia A.

Authors:  J Chen; D W Chung; J Le; M Ling; B A Konkle; J A López
Journal:  J Thromb Haemost       Date:  2013-09       Impact factor: 5.824

3.  In vitro and in vivo evaluation of the effect of elevated factor VIII on the thrombogenic process.

Authors:  M Golder; J Mewburn; D Lillicrap
Journal:  Thromb Haemost       Date:  2012-11-22       Impact factor: 5.249

4.  Compromised shear-dependent cleavage of type 2N von Willebrand factor variants by ADAMTS13 in the presence of factor VIII.

Authors:  Christopher G Skipwith; Sandra L Haberichter; Ashley Gehrand; X Long Zheng
Journal:  Thromb Haemost       Date:  2013-05-02       Impact factor: 5.249

5.  Probing ADAMTS13 substrate specificity using phage display.

Authors:  Karl C Desch; Colin Kretz; Andrew Yee; Robert Gildersleeve; Kristin Metzger; Nidhi Agrawal; Jane Cheng; David Ginsburg
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

6.  Mice deficient in the anti-haemophilic coagulation factor VIII show increased von Willebrand factor plasma levels.

Authors:  Klytaimnistra Kiouptsi; Alexandra Grill; Amrit Mann; Mareike Döhrmann; Maren Lillich; Sven Jäckel; Frano Malinarich; Henning Formes; Davit Manukyan; Saravanan Subramaniam; Avinash Khandagale; Cornelia Karwot; Serge C Thal; Markus Bosmann; Inge Scharrer; Kerstin Jurk; Christoph Reinhardt
Journal:  PLoS One       Date:  2017-08-24       Impact factor: 3.240

7.  Factor VIII binding affects the mechanical unraveling of the A2 domain of von Willebrand factor.

Authors:  Wenpeng Cao; Wenjing Cao; Wei Zhang; X Long Zheng; X Frank Zhang
Journal:  J Thromb Haemost       Date:  2020-07-23       Impact factor: 5.824

8.  Expression and assembly of largest foreign protein in chloroplasts: oral delivery of human FVIII made in lettuce chloroplasts robustly suppresses inhibitor formation in haemophilia A mice.

Authors:  Kwang-Chul Kwon; Alexandra Sherman; Wan-Jung Chang; Aditya Kamesh; Moanaro Biswas; Roland W Herzog; Henry Daniell
Journal:  Plant Biotechnol J       Date:  2017-12-07       Impact factor: 9.803

9.  von Willebrand Factor as a Predictor for Transplant-Associated Thrombotic Microangiopathy.

Authors:  Zhenzhen Xu; Chengwei Luo; Peilong Lai; Wei Ling; Suijing Wu; Xin Huang; Lisi Huang; Guanrong Zhang; Xin Du; Jianyu Weng
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.